Overview of Drugs Approved, in Trial and in the Pipeline for Differentiated Thyroid Cancer
Marcia Brose MD PhD
Presented at the 83rd Annual Meeting of the ATA
October 16-20, 2013
Home » 2013 Overview of Drugs Approved, in Trial and in the Pipeline for Differentiated Thyroid Cancer
Overview of Drugs Approved, in Trial and in the Pipeline for Differentiated Thyroid Cancer
Marcia Brose MD PhD
Presented at the 83rd Annual Meeting of the ATA
October 16-20, 2013
An Update on Novel Therapies for Advanced Thyroid Cancer:
When to Start and What to Use
Sponsored by a continuing medical education grant from AstraZeneca
Chair: Mimi Hu
An Update on Novel Therapies for Advanced Thyroid Cancer:
When to Start and What to Use
Marcia Brose MD PhD
Presented at the 83rd Annual Meeting of the ATA
October 16-20, 2013